All IJNR articles are published under the Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows broad reuse while ensuring authors receive proper attribution.

Authors retain copyright and grant IJNR the right to publish, distribute, and archive the work.

• Copyright ownership of the published article
• The right to reuse figures, tables, and text in future work
• Permission to deposit the final article in institutional repositories
• The ability to share the article on personal or lab websites

• Reuse, adapt, and build upon the work for any purpose
• Translate or incorporate content into educational materials
• Include the article in systematic reviews or meta analyses
• Text and data mining for research or policy insights

Reuse must include proper attribution to the authors, journal, year of publication, and DOI. Recommended attribution includes the article title, author names, journal name, year, and DOI.

• Link to the original article and DOI
• Indicate if changes were made
• Preserve citation details and author order

If your article includes third party figures, datasets, or copyrighted content, obtain permission from the rights holder and document it clearly. Materials not covered under CC BY should be labeled with appropriate credit lines.

• Confirm permissions for reproduced figures or tables
• Provide credit lines for reused content
• Document patient consent for identifiable images
• Ensure all third party images and datasets have documented permissions.
• Confirm patient consent for identifiable images or supplementary materials.
• State any limitations on derivative works or commercial use where applicable.
• Provide licensing statements for supplementary files and appendices.

IJNR is committed to rigorous, transparent publishing of negative, null, and inconclusive results. We emphasize reproducible methods, full outcome reporting, and ethical compliance across all article types.

The editorial office supports authors, editors, and reviewers with clear guidance and responsive communication. For questions about scope or workflow, contact [email protected].

We encourage complete reporting, data availability, and candid discussion of limitations to strengthen the research record.